BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 105577)

  • 1. Complement and coagulation: causative considerations in contrast catastrophies.
    Lasser EC; Slivka J; Lang JH; Kolb WP; Lyon SG; Hamblin AE; Nazareno G
    AJR Am J Roentgenol; 1979 Feb; 132(2):171-6. PubMed ID: 105577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation systems in contrast idiosyncrasy.
    Lasser EC; Hang JH; Hamblin AE; Lyon SG; Howard M
    Invest Radiol; 1980; 15(6 Suppl):S2-5. PubMed ID: 7203924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Complement activation after the intravascular administration of contrast media: a comparison between ionic and nonionic x-ray contrast media].
    Hoffmeister HM; Fuhrer G; Platten HP; Heller W
    Rofo; 1987 Dec; 147(6):673-5. PubMed ID: 2827265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoid-induced elevations of C1-esterase inhibitor: a mechanism for protection against lethal dose range contrast challenge in rabbits.
    Lasser EC; Lang JH; Lyon SG; Hamblin AE; Howard M
    Invest Radiol; 1981; 16(1):20-3. PubMed ID: 7216691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biological effects and the mechanism of complement activation--interaction among complement, coagulation, fibrinolysis and kinin generation system].
    Kondo M; Takemura S
    Nihon Rinsho; 1979 May; 37(5):1038-43. PubMed ID: 381718
    [No Abstract]   [Full Text] [Related]  

  • 6. Changes in complement and coagulation factors in a patient suffering a severe anaphylactoid reaction to injected contrast material: some considerations of pathogenesis.
    Lasser EC; Lang JH; Lyon SG; Hamblin AE
    Invest Radiol; 1980; 15(6 Suppl):S6-12. PubMed ID: 7203950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The in vitro activation of complement by radiologic contrast materials and its inhibition with epsilon-aminocaproic acid.
    Neoh SH; Sage MR; Willis RB; Roberts-Thomson P; Bradley J
    Invest Radiol; 1981; 16(2):152-8. PubMed ID: 6783593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial studies on the administration of C1-esterase inhibitor to patients with septic shock or with a vascular leak syndrome induced by interleukin-2 therapy.
    Hack CE; Ogilvie AC; Eisele B; Jansen PM; Wagstaff J; Thijs LG
    Prog Clin Biol Res; 1994; 388():335-57. PubMed ID: 7831367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Activation of plasma cascade systems in sepsis: role of C1 inhibitors].
    Zeerleder S; Caliezi C; Redondo M; Devay J; Wuillemin WA
    Schweiz Med Wochenschr; 1999 Oct; 129(39):1410-7. PubMed ID: 10542999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clivarin and other LMWHs in an ex vivo cardiopulmonary bypass model. Studies on contact activation.
    Heller W; Wendel HP
    Blood Coagul Fibrinolysis; 1993 Dec; 4 Suppl 1():S45-54. PubMed ID: 8180329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal perfusion.
    Wachtfogel YT; Kucich U; Hack CE; Gluszko P; Niewiarowski S; Colman RW; Edmunds LH
    J Thorac Cardiovasc Surg; 1993 Jul; 106(1):1-9; discussion 9-10. PubMed ID: 7686593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of complement inhibition and heparin coating on artificial surface-induced leukocyte and platelet activation.
    LappegÄrd KT; Fung M; Bergseth G; Riesenfeld J; Lambris JD; Videm V; Mollnes TE
    Ann Thorac Surg; 2004 Mar; 77(3):932-41. PubMed ID: 14992902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disseminated intravascular coagulation induced by liquoid in the rat. I. Correlation of hematologic and complement abnormalities with renal lesions studied by light, fluorescence, and electron microscopy.
    Urizar RE; Sherer G; Tartaglia A; Pickering RJ; Dodds WJ
    Lab Invest; 1975 Mar; 32(3):270-8. PubMed ID: 1123910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disseminated intravascular coagulation induced by liquoid in the rat. IV. Modification of the generalized Shwartzman reaction by ancrod and cobra venom factor.
    Urizar RE; Dodds WJ; Roth M; Rohloff J; Zdeb M; Largent JA
    Lab Invest; 1979 Jun; 40(6):645-54. PubMed ID: 221738
    [No Abstract]   [Full Text] [Related]  

  • 15. Radiographic contrast media and the coagulation and complement systems.
    Hoffmeister HM; Heller W
    Invest Radiol; 1996 Sep; 31(9):591-5. PubMed ID: 8877497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of C1-esterase inhibitor substitution on coagulation and cardiorespiratory parameters in an endotoxin-induced rabbit model of hypercoagulability.
    Scherer RU; Giebler RM; Schmidt U; Paar D; Kox WJ
    Semin Thromb Hemost; 1996; 22(4):357-66. PubMed ID: 8944422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steroids: theoretical and experimental basis for utilization in prevention of contrast media reactions.
    Lasser EC; Lang J; Sovak M; Kolb W; Lyon S; Hamlin AE
    Radiology; 1977 Oct; 125(1):1-9. PubMed ID: 897151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of plicatic acid on human serum complement includes interference with C1 inhibitor function.
    Giclas PC
    J Immunol; 1982 Jul; 129(1):168-72. PubMed ID: 6979566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administration of C1-esterase inhibitor during emergency coronary artery bypass surgery in acute ST-elevation myocardial infarction.
    Thielmann M; Marggraf G; NeuhÀuser M; Forkel J; Herold U; Kamler M; Massoudy P; Jakob H
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):285-93. PubMed ID: 16829095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of C1 inhibitor plus heparin in prevention of complement-mediated activation of endothelial cells in a model of xenograft hyperacute rejection.
    Dalmasso AP; Platt JL
    Transplant Proc; 1994 Jun; 26(3):1246-7. PubMed ID: 8029898
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.